sezolamide has been researched along with Chronic Primary Open Angle Glaucoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 10 (90.91) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosc, JM; Bron, AM; George, JL; Greve, EL; Gunning, FP; Lesure, P; Royer, JG; Sirbat, D | 1 |
| Béchetoille, A; Brunner-Ferber, FL; Buntinx, A; Clineschmidt, C; Gerling, J; Grehn, F; Gunning, F; Holder, D; Lippa, EA; Pfeiffer, N | 1 |
| Béchetoille, A; Gerling, J; Grehn, F; Greve, E; Gunning, F; Jaquet-Müller, F; Lippa, EA; Pfeiffer, N | 1 |
| Aasved, H; Airaksinen, PJ; Alm, A; Bertelsen, T; Calissendorff, B; Dithmer, O; Eriksson, LO; Gustad, L; Høvding, G; Lippa, EA | 1 |
| Bénichou, C; Bron, A; Clineschmidt, C; Flament, J; Gunning, F; Lesure, P; Lippa, EA; Panebianco, D; Royer, J; Sirbat, D | 1 |
| Deasy, DA; Epstein, DL; Higginbotham, EJ; Holder, DJ; Kass, MA; Lippa, EA; Schuman, JS; Shaw, B; Skuta, GL; Weinreb, RN | 1 |
| Garus, H; Grehn, F; Hennekes, R; Pfeiffer, N | 1 |
| Brunner-Ferber, FL; Garus, H; Grehn, F; Hennekes, R; Lippa, EA; Pfeiffer, N | 1 |
| Bechetoille, A; Brunner-Ferber, F; Diestelhorst, M; Krieglstein, GK; Lippa, E | 1 |
| Batenhorst, RL; Higginbotham, EJ; Kass, MA; Lippa, EA; Panebianco, DL; Wilensky, JT | 1 |
| Bron, AM; Brunner-Ferber, FL; Feicht, BI; Hofmann, HM; Lippa, EA; Panebianco, DL; Royer, JG; Von Denffer, HA | 1 |
11 trial(s) available for sezolamide and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study.
Topics: Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Double-Blind Method; Drug Delivery Systems; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Polysaccharides, Bacterial; Sulfonamides; Thiophenes | 1993 |
Sezolamide: additivity to timolol twice daily.
Topics: Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Sulfonamides; Thiophenes; Timolol | 1992 |
[Additive effect of timolol and the local carbonic anhydrase inhibitor MK-417 (sezolamide)].
Topics: Aged; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Sulfonamides; Thiophenes; Timolol | 1991 |
Multiple-dose, dose-response relationship for the topical carbonic anhydrase inhibitor MK-927.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Placebos; Sulfonamides; Thiophenes | 1991 |
Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors sezolamide and MK-927.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Stereoisomerism; Sulfonamides; Thiophenes | 1991 |
MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Sulfonamides; Thiophenes | 1991 |
[Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
Topics: Carbonic Anhydrase Inhibitors; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes | 1990 |
A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.
Topics: Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes | 1990 |
[Stereospecificity of lowering intraocular pressure using a locally administered carbonic anhydrase inhibitor].
Topics: Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Racemases and Epimerases; Sulfonamides; Thiophenes | 1990 |
MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carbonic Anhydrase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Time Factors; Visual Acuity | 1990 |
MK-927: a topically effective carbonic anhydrase inhibitor in patients.
Topics: Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Clinical Trials as Topic; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Placebos; Random Allocation; Sulfonamides; Thiophenes | 1989 |